The first human trial for an experimental vaccine targeting the Bundibugyo strain of Ebola has commenced, with a volunteer in the UK receiving the initial dose. This development comes as Ebola cases in DR Congo continue to rise, reaching 2,905.

The Ebola outbreak in the Democratic Republic of Congo has claimed over 200 lives, with confirmed cases increasing by nearly 40% in a week. Health officials warn the outbreak is far from under control, and there are no vaccines for the current Bundibugyo strain.